[1].负荷超声心动图在缺血性心脏病中的临床应用进展[J].心血管病学进展,2021,(1):47-51.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
　SONG Yuwei,JING Ling.Clinical Application of Stress Echocardiography in Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2021,(1):47-51.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
点击复制

负荷超声心动图在缺血性心脏病中的临床应用进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2021年1期
页码:
47-51
栏目:
综述
出版日期:
2021-01-25

文章信息/Info

Title:
Clinical Application of Stress Echocardiography in Ischemic Heart Disease
文章编号:
202005076
Author(s):
SONG Yuwei;  JING Ling
(Department of Cardiology,The First Affiliated Hospital of Harbin Medical University, Harbin 150001,Heilongjiang,China)
Keywords:
yocardial contrast echocardiography
DOI:
10.16806/j.cnki.issn.1004-3934.2021.01.000
Abstract:
In recent years,with the incidence of ischemic heart disease increasing year by year, non-invasive evaluation have attracted more and more attention. At present, stress echocardiography has become a relatively mature technology for diagnosis of ischemic heart disease,evaluation of viable myocardium,assessment of risk stratification and prognosis. With the development of new ultrasonic technologies such as myocardial contrast echocardiography, speckle-tracking imaging and three-dimensional echocardiography,the diagnostic accuracy and specificity of stress echocardiography has been improved,which is believed to be more widely used in clinical practice in the future

参考文献/References:

[1] Shemarova IV, Nesterov VP. Molecular basis of cardioprotection in ischemic heart disease[J]. J Evol Biochem Phys,2019,55(3):163-173.
[2] Jensen RV,Hjortbak MV,B?tker HE. Ischemic heart disease:an update[J]. Semin Nucl Med,2020,50(3):195-207.
[3] 翟恒博,刘俊. 缺血性心脏病再认识[J]. 心血管病学进展,2016,37(4):395-400.
[4] Gibbons RJ,Balady GJ,Bricker JT,et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association task force on practice guidelines (committee to update the 1997 exercise testing guidelines)[J]. J Am Coll Cardiol,2002,40(8):1531-1540.
[5] Steeds RP,Wheeler R,Bhattacharyya S,et al. Stress echocardiography in coronary artery disease:a practical guideline from the British Society of Echocardiography[J]. Echo Res Pract,2019,6(2):G17-G33.
[6] Pellikka PA,Arruda-Olson A,Chaudhry FA,et al. Guidelines for performance,interpretation,and application of stress echocardiography in ischemic heart disease:from the American Society of Echocardiography[J]. J Am Soc Echocardiogr,2020,33(1):1-41.
[7] 张运,尹立雪,邓又斌,等.负荷超声心动图规范化操作指南[J]. 中国医学影像技术,2017,33(4):632-638.
[8] Attenhofer CH,Pellikka PA,Roger VL,et al. Impact of atropine injection on heart rate response during treadmill exercise echocardiography:a double-blind randomized pilot study[J]. Echocardiography,2000,17(3):221-227.
[9] Pellikka PA,Nagueh SF,Elhendy AA,et al. American Society of Echocardiography recommendations for performance,interpretation,and application of stress echocardiography[J]. J Am Soc Echocardiogr,2007,20(9):1021-1041.
[10] Pellikka PA,Roger VL,Oh JK,et al. Stress echocardiography. Part II. Dobutamine stress echocardiography:techniques,implementation,clinical applications,and correlations[J]. Mayo Clin Proc,1995,70(1):16-27.
[11] Tsutsui JM,Osório Altamiro AFF,Lario FAC,et al. Comparison of safety and efficacy of the early injection of atropine during dobutamine stress echocardiography with the conventional protocol[J]. Am J Cardiol,2004,94(11):1367-1372.
[12] Varga A,Garcia MAR,Picano E. Safety of stress echocardiography[J]. Am J Cardiol,2006, 98(4):541-543.
[13]Sicari R,Nihoyannopoulos P,Evangelista A,et al. Stress echocardiography expert consensus statement—Executive summary:European Association of Echocardiography(EAE)(a registered branch of the ESC)[J]. Eur Heart J,2009,30(3):278-289.
[14]Cullen MW,Pellikka PA. Recent advances in stress echocardiography[J]. Curr Opin Cardiol,2011,26(5):379-384.
[15]吴执茗,李晨,徐立彦. 冠状动脉微血管功能障碍的诊断方法研究进展[J]. 心血管病学进展,2019,40(1):41-45.
[16]Cremer P,Hachamovitch R,Tamarappoo B.Clinical decision making with myocardial perfusion imaging in patients with known or suspected coronary artery disease[J]. Semin Nucl Med,2014,44(4):320-329.
[17]Bhat A,Gan GCH,Tan TC,et al. Myocardial viability:from proof of concept to clinical practice[J]. Cardiol Res Pract,2016,2016:1020818.
[18]Ling LH,Christian TF,Mulvagh SL,et al. Determining myocardial viability in chronic ischemic left ventricular dysfunction:a prospective comparison of rest-redistribution thallium 201 single-photon emission computed tomography,nitroglycerin-dobutamine echocardiography,and intracoronary myocardial contrast echocardiography[J]. Am Heart J,2006,151(4):882-889.
[19]Chaowalit N,McCully RB,Callahan MJ,et al. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events:long-term follow-up of 3014 patients[J]. Eur Heart J,2006,27(24):3039-3044.
[20]Yao SS, Qureshi E,Sherrid MV,et al. Practical applications in stress echocardiography:risk stratification and prognosis in patients with known or suspected ischemic heart disease[J]. J Am Coll Cardiol,2003,42(6):1084-1090.
[21]Tweet MS,Arruda-Olson AM,Anavekar NS,et al. Stress echocardiography:what is new and how does it compare with myocardial perfusion imaging and other modalities?[J]. Curr Cardiol Rep,2015,17(6):1-10.
[22]Takeuchi M,Yoshitani H,Miyazaki C,et al. Color kinesis during contrast-enhanced dobutamine stress echocardiography:feasibility and applicability[J]. Circ J,2003,67(1):49-53.
[23]Leong-Poi H,Rim SJ,Le DE,et al. Perfusion versus function:the ischemic cascade in demand ischemia:implications of single-vessel versus multivessel stenosis[J]. Circulation,2002,105(8):987-992.
[24]Moir S,Haluska BA,Jenkins C,et al. Incremental benefit of myocardial contrast to combined dipyridamole-exercise stress echocardiography for the assessment of coronary artery disease[J]. Circulation,2004,110(9):1108-1113.
[25]Korosoglou G,Hansen A,Hoffend J,et al.Comparison of real-time myocardial contrast echocardiography for the assessment of myocardial viability with fluorodexyglucose-18 positron emission tomography and dobutamine stress echocardiography[J]. Am J Cardiol,2004,94(5):570-576.
[26]张源祥,邱银汝,梁志尧,等. 三磷酸腺苷和多巴酚丁胺负荷超声造影在冠心病诊断中的对比研究[J/CD]. 中华医学超声杂志电子版,2020,17(4):335-340.
[27]Porter TR,Smith LM,Wu J,et al. Patient outcome following 2 different stress imaging approaches:a prospective randomized comparison[J]. J Am Coll Cardiol,2013,61(24):2446-2455.
[28]Li X, He S,Zhang YS,et al. Resting myocardial contrast echocardiography for the evaluation of coronary microcirculation dysfunction in patients with early coronary artery disease[J]. Clin Cardiol,2016,39(8):453-458.
[29]Yang N,Su YF,Li WW,et al. Microcirculation function assessed by adenosine triphosphate stress myocardial contrast echocardiography and prognosis in patients with nonobstructive coronary artery disease[J]. Medicine,2019,98(27):e15990.
[30]周肖,智光. 小剂量多巴酚丁胺负荷超声心动图结合组织多普勒成像诊断存活心肌的量化指标评价[J]. 中华医学超声杂志(电子版),2007,4(2):86-89.
[31]周发展. 组织多普勒结合腺苷负荷超声心动图试验诊断冠心病的临床研究[J]. 中华医学超声杂志(电子版),2012,9(3):244-250.
[32]巩雷,李东野,陈军红,等. 超声斑点追踪应变率成像技术结合多巴酚丁胺负荷试验评价冠状动脉粥样硬化性心脏病患者存活心肌的价值[J/CD]. 中华医学超声杂志电子版),2012,9(12):1045-1051.
[33]Uusitalo V,Luotolahti M,Pietil? M,et al. Two-dimensional speckletracking during dobutamine stress echocardiography in the detection of myocardial ischemia in patients with suspected coronary artery disease[J]. J Am Soc Echocardiogr,2016,29(5):470-479.
[34]Shah BN,Balaji G,Alhajiri A,et al. Incremental diagnostic and prognostic value of contemporary stress echocardiography in a chest pain unit:mortality and morbidity outcomes from a real-world setting[J]. Circ Cardiovasc Imaging,2013,6(2):202-209.
[35]Johri AM,Chitty DW,Hua L,et al. Assessement of image quality in real time three-dimensional dobutamine stress echocardiography:an integrated 2D/3D approach[J]. Echocardiography,2015,32(3):496-507.

更新日期/Last Update: 2021-03-22